Maximize the translational potential of genomic, proteomic and metabolomic platforms.
Potentially transformative biomarkers for disease diagnosis, screening purposes and prognosis or drug therapy slowly, if ever, find their way into clinical practice.
Translational scientists are faced with a dizzying array of -omics platforms. Consider this scenario: a translational scientist has developed or has access to a well-phenotyped patient population in which genomic, proteomic and/or metabolomic data could be transformative in thinking about that population. Success will require interfaces between the translational scientist, an -omics platform and the ability to analyze large data sets.
We help translational researchers understand and use the appropriate cutting edge technology essential to rapidly and efficiently discover a target or biomarker critical for understanding, treating or diagnosing human diseases.